Bohdana Doskaliuk
Bohdana D. is a PhD fellow at the Ivano-Frankivsk National Medical University, Ukraine. Her main research interests include the pathogenesis of SSc-ILD and animal models of rheumatic diseases. Bohdana D. is a member of the EMEUNET Country Liasson Sub-Committee.
| Poster 0014 | Sunday, 12.11.23 09.00 Poster Session A (Genetics, Genomics & Proteomics Poster) Author: Laurynenka, V (USA) Title: THE 330 GENETIC RISK LOCI OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) NOW KNOWN ARE CONSONANT WITH MULTIPLE CAUSAL MECHANISMS INVOLVING EPSTEIN-BARR VIRUS (EBV)-ENCODED TRANSCRIPTION CO-FACTORS (TFS) IN EBV-INFECTED B CELLS  It presents connection between EBV infection and SLE autoimmunity, revealing shared genetic mechanisms and highlighting the role of EBV-transformed B cells in SLE development. |
| Poster 0020 | Sunday, 12.11.23 09.00 Poster Session A (Genetics, Genomics & Proteomics Poster) Author: Sequí-Sabater, JM (Spain) Title: THE INFLAMMATORY PROTEOME IN SJÖGREN’S SYNDROME IDENTIFIES NEW BIOMARKERS AND RELEVANT CLINICAL SUBGROUPS It recognizes the unique molecular patterns in individuals suffering from primary Sjögren’s syndrome. |
| Oral 1668 | Monday, 13.11.23 16.00 Abstracts Session (Systemic Sclerosis & Related Disorders – Basic Science) Author: Yang, M (USA) Title: CELL SPECIFIC MOLECULAR PROFILING OF SCLERODERMA ASSOCIATED INTERSTITIAL LUNG DISEASE SUBTYPES It reveals variations in cellular composition and molecular pathways, highlighting potential insights into the pathogenesis of SSD-ILD. |
| Oral 1595 | Monday, 13.11.23 14.00 Abstract session (Osteoarthritis & Joint Biology – Basic Science) Author: Kawata, M (USA) Title: PHARMACOLOGICAL MODULATION OF KRÜPPEL-LIKE FACTOR 4 REDUCES THE SEVERITY OF EXPERIMENTAL OSTEOARTHRITIS VIA TISSUE PROTECTION AND REGENERATION It highlights mocetinostat, a class I histone deacetylase (HDAC) inhibitor, as a promising OA treatment candidate. |
| Poster 1733 | Tuesday, 14.11.23 09.00 Poster Session C (RA – Animal Models Poster) Author: Aripova, N (UK) Title: PLATELET-DERIVED GROWTH FACTOR IS A MEDIATOR OF DISEASE IN AN ANIMAL MODEL OF RHEUMATOID-ASSOCIATED INTERSTITIAL LUNG DISEASE It indicates a potential for developing novel treatments targeting PDGF-BB in RA-ILD, addressing a critical unmet need in the field. |
| Oral 2438 | Tuesday, 14.11.23 14.00 Abstract Session (Spondyloarthritis Including Psoriatic Arthritis – Basic Science) Author: Tynan, O (Ireland) Title: SYNOVIAL TISSUE SINGLE-CELL ANALYSIS DEMONSTRATES DIFFERENTIAL FIBROBLAST POPULATIONS BETWEEN RA AND PSA WHICH DISPLAY DISTINCT FUNCTION It highlights differences in synovial fibroblasts’ phenotypes, functionality, and disease-related pathways in RA and PsA. |